Chios mastic gum (CMG), the resin from Pistacia lentiscus L. var. Chia, is a valuable natural product with a long history of therapeutic use and significant economic impact. However, its authenticity is increasingly challenged by adulteration with chemically similar resins, particularly Pistacia atlantica. This study presents a robust ¹H NMR-based metabolomics approach combined with principal component analysis (PCA) to authenticate CMG and distinguish it from other resins. A total of 131 resin samples-including 71 authentic CMG samples from four Chios subregions-were analyzed. A distinct metabolic signature for CMG was revealed, primarily characterized by high levels of masticadienonic acid (MNA), isomasticadienonic acid (IMNA), oleanonic aldehyde, and cis-1,4-poly-β-myrcene. The resulting chemometric model effectively differentiated CMG from adulterants, including Iranian mastic gum (IMG) and aged CMG, and identified mislabeled commercial samples. Two authentication indices (MA Index-1 and MA Index-2) were developed based on key metabolite concentrations and their ratios, providing a quantifiable, reproducible framework for CMG quality control. This method enables rapid, non-destructive authentication without extensive sample preparation or reference standards, offering a valuable tool for safeguarding the integrity of CMG in commercial and regulatory settings.
No takes yet. Share an insight, caveat, or question.
Akrivousi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: